<DOC>
<DOCNO>
EP-0005250
</DOCNO>
<TEXT>
<DATE>
19791114
</DATE>
<IPC-CLASSIFICATIONS>
<main>C07D-233/60</main> C07D-521/00 A61K-31/415 
</IPC-CLASSIFICATIONS>
<TITLE>
hydroxypropyl imidazoles, their preparation and medicaments containing them.
</TITLE>
<APPLICANT>
bayer ag de  <sep>bayer aktiengesellschaft<sep>bayer ag51368 leverkusende<sep>bayer ag<sep>
</APPLICANT>
<INVENTOR>
buchel karl heinz prof dr<sep>haller ingo dr<sep>plempel manfred dr<sep>regel erik<sep>buchel, karl heinz, prof. dr.<sep>haller, ingo, dr.<sep>plempel, manfred, dr.<sep>regel, erik<sep>büchel, karl heinz, prof. dr.bergerheide 62d-5600 wuppertal 1de<sep>haller, ingo, dr.viktoriastrasse 99d-5600 wuppertal 1de<sep>plempel, manfred, dr.pahlkestrasse 5d-5600 wuppertal 1de<sep>regel, erikbergerheide 72ad-5600 wuppertal 1de<sep>buchel, karl heinz, prof. dr.<sep>haller, ingo, dr.<sep>plempel, manfred, dr. <sep>regel, erik  <sep>büchel, karl heinz, prof. dr.bergerheide 62d-5600 wuppertal 1de<sep>haller, ingo, dr.viktoriastrasse 99d-5600 wuppertal 1de<sep>plempel, manfred, dr.pahlkestrasse 5d-5600 wuppertal 1de<sep>regel, erikbergerheide 72ad-5600 wuppertal 1de<sep>
</INVENTOR>
<ABSTRACT>
The present invention relates to novel hydroxypropylimidazoles, multiple methods for their preparation and their use as a medicament, in particular as antimycotics.In addition to good antifungal in vitro efficacy, the hydroxypropyl imidazoles according to the invention show a better therapeutically usable in vivo effectiveness against Candida than that known from the prior art 1- [2,4-dichloro-α- (2,4-dichlorobenzyloxy) -phenethyl] -imidazol nitrate.The active compounds according to the invention thus represent a valuable enrichment of the pharmacy.
</ABSTRACT>
</TEXT>
</DOC>
